Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Corynebacterium urealyticum

Munoz-Bellido J.L., S. Munoz-Criado, and J.A. Garcia-Rodriguez (1996). In vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). Journal of Antimicrobial Chemotherapy 37 1005-1009. [Pg.277]

Yague, G., Segovia, M., and Valero-Guillen, P.L., 2003, Phospholipid composition of several clinically relevant Corynebacterium species as determined by mass spectrometry An unusual fatty acyl moiety is present in inositol-containing phospholipids of Corynebacterium urealyticum. Microbiology 149 1675-1685. [Pg.133]

C. Clinical Uses Erythromycin is effective in the treatment of infections caused by Mycoplasma pneumoniae, corynebacterium. Chlamydia trachomatis, Legionella pneumophila, Ureaplasma urealyticum, and Bordetella pertussis. The drug is also active against gram-positive cocci, including pneumococci and beta-lactamase-producing staphylococci (but not MRSA strains). [Pg.388]

See other pages where Corynebacterium urealyticum is mentioned: [Pg.109]    [Pg.96]    [Pg.109]    [Pg.96]    [Pg.332]   
See also in sourсe #XX -- [ Pg.64 ]



SEARCH



Corynebacterium

© 2024 chempedia.info